Publication | Closed Access

RalA requirement for v-Src- and v-Ras-induced tumorigenicity and overproduction of urokinase-type plasminogen activator: involvement of metalloproteases

Malignant DiseaseV-ras-induced TumorigenicityMedicineOncogenic AgentImmunologyRala RequirementCell BiologyCancer BiologyRadiation OncologyCancer ResearchTumor BiologyUrokinase-type Plasminogen Activator